Submission to Biomanufacturing Capacity Consultation

The pandemic has brought to light the importance of the life sciences sector and the vital role it plays in health outcomes as well as the economy. Coming out of the pandemic, Canada has the opportunity to improve the business environment for life sciences companies to build stronger and more resilient health systems, supported by vibrant biotechnology and medical technology sectors that delivers health innovations. Alignment and coordination between the federal government and the provinces will be essential to participate in, and benefit from, the global supply chains that safeguard the public during global health crises.